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Abstract
Background: To overcome the increasing resistance of pathogens to existing antibiotics the 106
’20 Initiative declared the
urgent need for a global commitment to develop 10 new antimicrobial drugs by the year 2020. Naturally occurring animal
antibiotics are an obvious place to start. The recently sequenced genomes of mammals that are divergent from human and
mouse, including the tammar wallaby and the platypus, provide an opportunity to discover novel antimicrobials. Marsupials
and monotremes are ideal potential sources of new antimicrobials because they give birth to underdeveloped
immunologically naı ¨ve young that develop outside the sterile confines of a uterus in harsh pathogen-laden environments.
While their adaptive immune system develops innate immune factors produced either by the mother or by the young must
play a key role in protecting the immune-compromised young. In this study we focus on the cathelicidins, a key family of
antimicrobial peptide genes.
Principal Finding: We identified 14 cathelicidin genes in the tammar wallaby genome and 8 in the platypus genome. The
tammar genes were expressed in the mammary gland during early lactation before the adaptive immune system of the
young develops, as well as in the skin of the pouch young. Both platypus and tammar peptides were effective in killing a
broad range of bacterial pathogens. One potent peptide, expressed in the early stages of tammar lactation, effectively killed
multidrug-resistant clinical isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii.
Conclusions and Significance: Marsupial and monotreme young are protected by antimicrobial peptides that are potent,
broad spectrum and salt resistant. The genomes of our distant relatives may hold the key for the development of novel
drugs to combat multidrug-resistant pathogens.
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Introduction
Over the past two decades a large number of antimicrobial
peptides have been identified in plants, animals and microorganisms.
These endogenous antibiotic peptides play a key role in the innate
immune system and areafirstlineof defensein protecting theinternal
and external body surfaces of the host. The best known antimicrobial
peptide gene families include the defensins and the cathelicidins. In
this paper we focus on the cathelicidin gene family. Cathelicidin genes
are characterized by a conserved signal sequence and pro-peptide
region but are highly variable in the C-terminal domain that encodes
the mature antimicrobial peptide, which is released by elastase
cleavage. The active peptides vary in length both within a species and
between species and range from 12–100 amino-acid residues [1,2].
Cathelicidins are found in neutrophils and macrophages, as well as
epithelial cells of the testis, skin, gastrointestinal tract and respiratory
tract (reviewed in [2]). Cathelicidins interact with and destroy Gram-
positive and Gram-negative bacteria, protozoa and fungi via
electrostatic interactions between their positively charged peptides
and the negatively charged molecules found in the cell membranes of
their targets. Besides their direct antimicrobial function, cathelicidins
also play a role in inflammation and in dampening of excessive
inflammation, cell proliferation and migration, immune modulation,
wound healing, angiogenesis and the release of cytokines and
histamine (reviewed in [2,3]).
The best studied cathelicidin is human LL-37, the only human
cathelicidin. It has anti-tumour and anti-HIV activity [4].
Recurrent bacterial infections occur in patients with Chediak-
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cleave cathelicin pro-peptides [5]. Cathelicidin knockout mice are
susceptible to Group A Streptococccus, herpes simplex virus,
Escherichia coli and vaccinia virus (reviewed in [6]). In the rat,
cathelicidins protect against lethal sepsis caused by Gram-
negative bacteria [7].
During the course of evolution, nature has developed a vast
array of antimicrobial peptides. Each species contains a different
set of related genes that reveal signatures of different selective
forces. Cathelicidin genes have been identified in the invertebrate
hagfish [8] and in a range of vertebrates, including mammals
[9,10,11], chickens [12,13,14], fish [15,16] and reptiles [17,18,
19,20].
Marsupials and monotremes hold an important position in the
vertebrate phylogenetic tree because they represent two of the
three extant mammalian lineages. Marsupials and eutherian
mammals last shared a common ancestor between 130 and 148
million years ago, while monotremes and therian mammals
(marsupials and eutherians) diverged about 166 million years ago
[21,22,23]. Marsupials and monotremes differ from eutherian
mammals primarily in their mode of reproduction. Marsupials
give birth to underdeveloped (altricial) young after a short
gestation, which in the tammar wallaby (Macropus eugenii) is only
26.5 days [24]. At birth, the neonate weighs only 440mg and is
16–17mm long [24]. This developmental stage is roughly
equivalent to a 40 day human embryo or a 15 day mouse
embryo. The young remains in the pouch for 9–10 months,
supported by a long and physiologically sophisticated lactation.
Initially the young are permanently attached to a teat, but later
they begin to release the teat periodically whilst still in the pouch.
The mother’s milk undergoes compositional changes over time
ensuring that the nutritional supply to the young is specifically
matched to each developmental stage [25]. At birth the wallaby
does not have a differentiated immune system. Cells involved in
adaptive immunity are not seen until about 35 days after birth
[26,27] and immunocompetence develops around 90–100 post
partum [28].
Monotremes lay eggs and the young hatch at a very early stage
in development similar to that of the marsupial neonate. The
platypus (Ornithorhynchus anatinus) lays up to 3 leathery-shelled eggs
,15–21 days after mating [29]. After a 10 day incubation period,
young approximately 15mm in length emerge [30]. Much of the
development, including that of the immune system, occurs before
weaning. During the three to four months before they leave the
burrow the young grow from ,1.5 cm to ,40 cm [30].
Platypuses do not have teats but the milk is secreted via
mammary patches on the female’s abdomen. It is not known
exactly when platypus immune tissues reach maturity, but by the
time platypuses are adults, they possess a range of lymphoid
tissues that are histologically similar to those of therian mammals
[31].
Unlike eutherians, whose immune systems develop in the
relatively sterile confines of the mother’s uterus, the marsupial and
monotreme immune systems develop while exposed to a range of
pathogens in the pouch and in the burrow. In eutherians,
cathelicidins play a crucial role in neonatal defense. They have
been detected in skin of neonatal mice and humans, in human
milk, and LL-37 is found in the vernix caseosa, a creamy substance
that covers the healthy infant at birth (reviewed in [32]). Therefore
it is likely that the marsupial and monotreme genomes have also
evolved under evolutionary pressure to protect immunologically
naı ¨ve young with broad spectrum antibiotics and that their
genomes will reveal a source of novel antimicrobial peptides that
may provide unique answers to antibiotic resistance.
The recent sequencing of the tammar wallaby genome [33] and
the platypus genome [23] allow discovery of these divergent
peptides using bioinformatics strategies. There are seven cathe-
licidin genes in the tammar mammary gland EST library [32],
expressed in adult leukocytes and in primary and secondary
lymphoid organs of the pouch young over the first 120 days of life.
An eighth cathelicidin, recently identified, is expressed in spleen
and gastrointestinal tract of newborn animals and in most tissues
by seven days after birth [34]. We identified eight cathelicidin
genes in the platypus genome [23]. All were expressed in adult
brain, kidney, liver, lung, spleen and testis [35]. Surprisingly, none
of them were expressed in the single platypus milk sample
available to us [35]. It is important to note that access to platypus
samples for scientific research is difficult. In the wild, adults are
trapped in nets without their young, as the young remain in the
burrow while the mother forages. Therefore, it is impossible to
know the stage of the mother’s lactation. It is possible that milk
samples from other stages of lactation could have yielded a
different result. Due to ethical and conservation concerns, further
study of monotreme developmental immunology is not possible at
this time and awaits opportunistic sampling.
In this paper we describe functional testing of antimicrobial
peptides identified through genome data-mining and support this
with expression studies that confirm that marsupials (and probably
monotremes) use these powerful broad-spectrum peptides to
protect themselves and their young from a diverse range of
pathogens found in the pouch (and in the soil).
Results and Discussion
Identification of cathelicidin genes
Fourteen divergent cathelicidin genes were identified in the
tammar genome, twelve in the opossum and eight in the platypus
(Fig. 1). Sequences were identified using a PFAM hidden Markov
model and full-length coding sequences were extracted by gene
prediction. The phylogenetic relationships of cathelicidins are
shown in Fig. 1. Proteins selected for active C-terminal peptide
prediction and testing are indicated.
Expression of cathelicidin genes
Tammar cathelicidin genes were expressed in the mammary
gland throughout lactation, consistent with a role in protection of
immuno-naı ¨ve young. Five out of six genes tested were down-
regulated after 100 days post partum (Fig. 2a) corresponding to the
time when the young achieve immune competence. Similar
cathelicidin expression also occurred in the skin of pouch young
and adult in four of the six genes tested (Fig. 2b).
Evolution of cathelicidin genes
Marsupial and monotreme antimicrobial peptides are ancient,
diverging from each other approximately 211 million years ago
(101–340 million years, 95% credibility interval (CI)). Mammalian
ancestors likely expressed a broad repertoire of cathelicidin
peptides to protect their young. Over time, with the evolution of
longer gestation periods and the birth of young with greater
immune competence, cathelicidin genes were lost from the
eutherian lineage, because humans and mice have only one
cathelicidin gene. Recent gene duplications in sheep, cows and
pigs, ,53 MYA (27–80, 95% CI) (Fig. 1) were likely driven by
increased pathogen pressures in herd animals.
The high level of sequence divergence of the marsupial and
monotreme cathelicidin genes (tammar peptides share ,28%
amino-acid identity with each other) suggests that they should
have the potential to inhibit a wide range of microbial pathogens.
Marsupial and Monotreme Antimicrobial Peptides
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We selected four divergent tammar (wallaby antimicrobial 1 and
2:WAM1 and 2) and platypus antimicrobial 1 and 2 (PAM1 and
PAM2) peptides to synthesize and test (Fig 1). All four killed the
Gram-positive bacteria Bacillus subtilis, Staphylococcus aureus, Strepto-
coccus uberis and Strep. pyogenes, and the Gram-negative bacteria
Escherichia coli, Salmonella choleraesuis and P. aeruginosa (Table 1).
PAM2, WAM1 and WAM2 also killed the fungal pathogen Candida
albicans (Table 1). Our four divergent peptides were more potent
than the human cathelicidin peptide LL-37 which was less effective
against the seven bacteria tested and did not kill C. albicans.T h e
platypus peptides had distinct activity profiles, with PAM2 active
against C. albicans and PAM1 more potent against S. aureus
A phylogenetic approach to designing additional
antimicrobial peptides
A phylogenetic approach was used to design additional
antimicrobial peptides. An ancestral peptide (WAM=
Figure 2. Tammar cathelicidin gene expression in the mammary gland throughout lactation and in pouch young skin. D=Day;
PY=pouch young. Cath1 and Cath5 correspond to WAM1 and WAM2, respectively. (a) Tammar cathelicidin gene expression in the mammary gland
throughout the 350 days of lactation. (b) Tammar cathelicidin gene expression in male D20–D120 pouch young skin and adult lactating female pouch
skin. Female pouch young skin and adult non-lactating pouch skin showed similar expression patterns (not shown). Each age group is represented by
three different samples and mammary gland and thymus tissues were used as positive controls (+). No template controls (–) were clean.
doi:10.1371/journal.pone.0024030.g002
Figure 1. Phylogenetic tree demonstrating superior diversity of antimicrobial peptides in non-eutherian mammals. Tammar
cathelicidin peptides. WAM1 (a) – KRGFGKKLRKRLKKFRNSIKKRLKNFNVVIPIPLPG from MaeuCath1 (Genbank EF624481.1), WAM2 (b) -KRGLWESLKR-
KATKLGDDIRNTLRNFKIKFPVPRQG from MaeuCath5 (Genbank EF624484.1), Ancestral WAM (*)- RRGFWKRLRRRLRRFGDRIRNRFRNFREKLPDPFPG.
Platypus cathelicidin peptides PAM1 (c) – RTKRRIKLIKNGVKKVKDILKNNNIIILPGSNEK from OranCath1 [23] and PAM2 (d) – RPWAGNGSVH-
RYTVLSPRLKTQ from OranCath2 [23].
doi:10.1371/journal.pone.0024030.g001
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designed using MaeuCath1, 3, 5, 6 and 7 and three methods:
PAML [36], GASP [37] and Ancescon [38]. 6/40 amino acid
positions in the putative ancestral peptide were ambiguous and in
these positions the Ancescon predicted residues were selected. We
predict this peptide originated ,59 MYA (Fig. 1) and is ancestral
to the major clade of marsupial antimicrobial peptides including
the modern active peptides WAM1 and WAM2. This ancestral
peptide from the Paleocene had broad-spectrum activity and was
approximately ten times more effective than LL-37 at killing E.
coli, and P. aeruginosa. The archaic peptide had particularly potent
activity against the mastitis pathogens Strep. pyogenes and Strep. uberis
(Table 1), suggesting that an ancestral function included mammary
gland protection. This approach provides a new avenue to
investigate ancient peptides and their immune functions.
WAM1- highly potent but not toxic
The tammar peptide WAM1 was found to be remarkably potent.
It is 3–80 times more effective than LL-37 against each of these
microbes and is ten times more effective against E. coli and B. subtilis
than antibiotics such as ampicillin, tetracycline and chlorampheni-
col (Table 2). WAM1 was selected for further studies (results
summarized in Table 3) as it was effective against Gram-negative
bacteria including P. aeruginosa, a bacterial species known to cause
untreatable infections due to its resistance to all current antibiotics.
We also tested nineteen clinical isolates of multidrug-resistant
microorganisms that are resistant to at least three antibiotics.
WAM1 killed multidrug-resistant gram-negative bacteria including
P. aeruginosa, A. baumannii and K. pneumoniae (Table 3). This is
significant as some of the P. aeruginosa isolates are also resistant to the
last-line therapy, colistin [39]. Unlike some other antimicrobial
peptides, eg LL37 [40], WAM1 is resistant to inhibition by high
(150–200 mM) NaCl concentrations (Table 4), which is relevant as
most alpha-helix antimicrobial peptides lose activity at high salt
Table 1. Antimicrobial activities of cathelicidin peptides.
Strains MIC (mM)
WAM1 WAM2 Ancestral WAM LL37 PAM1 PAM2
Gram-negative
E. coli DH5a 0.47 1.46 0.41 5.57 0.75 0.87
Sal. enterica (ATCC 14028) 1.14 1.58 0.96 4.30 0.47 1.11
P. aeruginosa (ATCC 27853) 0.77 1.29 2.06 .56 1.89 0.73
Gram-positive
B. subtilis 1.50 2.14 1.56 8.62 1.96 3.37
S. aureus (ATCC 25923) 1.01 1.39 1.42 3.01 0.56 2.42
Strep. pyogenes (ATCC 19615) 0.66 0.39 0.68 .55 0.73 0.83
Strep. uberis 1.22 0.63 0.07 2.24 0.25 0.51
Fungi
C. albicans (ATCC 753) 1.30 1.47 6.45 .56 .20 2.50
doi:10.1371/journal.pone.0024030.t001
Table 2. Comparison of WAM1 potency to antibiotics
ampicillin, tetracycline and chloramphenicol against E. coli.
MIC (mM) Relative potency of WAM1
Ampicillin 5.7 12 x
Tetracycline 4.5 10 x
Chloramphenicol 12.4 26 x
WAM1 0.47
doi:10.1371/journal.pone.0024030.t002
Table 3. Activity of WAM1 against antibiotic-resistant gram-
negative clinical isolates.
Isolate description MIC (mM)
P. aeruginosa (ATCC 27853) 0.95
P. aeruginosa 001* 1.90
P. aeruginosa 002* 0.95
P. aeruginosa 003* 0.47
P. aeruginosa 004* 1.90
P. aeruginosa 005* (colistin R) 0.95
P. aeruginosa 006* (colistin R) 0.95
P. aeruginosa 007* (colistin R) 0.95
P. aeruginosa 008* (colistin R) 0.95
P. aeruginosa 009* (colistin R) 0.95
P. aeruginosa 010* (colistin R) .30.4
P. aeruginosa 011* 0.47
P. aeruginosa 012* 1.90
P. aeruginosa 013* .30.4
P. aeruginosa 014* .30.4
A. baumannii (ATCC 19606) 1.90
A. baumannii 001* 0.95
A. baumannii 002* .15.2
A. baumannii 003* 1.90
K. pneumoniae (ATCC 13883) 0.47
K. pneumoniae 001* 1.90
K. pneumoniae 002* 0.95
K. pneumoniae 003* 7.59
The 19 antibiotic-resistant isolates are marked with an asterisk and those also
resistant to colistin are indicated.
doi:10.1371/journal.pone.0024030.t003
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suitable for applications in vivo [41,42,43,44]. WAM1 was rapidly
bactericidial, killing 99.9% of K. pneumoniae within 15 minutes
(Fig. 3). WAM1 was not hemolytic against human red blood cells
indicating potential for parenteral use in humans (Fig. 4). The
effectiveness of tammar cathelicidin WAM1 in killing multidrug-
resistant P. aeruginosa demonstrates the potential of these compounds
for treating life-threatening drug resistant infections.
Our data suggests that the function of WAM1 is to protect the
altritical neonate at birth, as clinically relevant bacteria affected by
WAM1 (such as A. baumanni and E. coli) were detected in the
tammar pouch around the time of birth (Table 5). Consistent with
previous reports [45], we also identified a number of potentially
novel bacterial species in the pouch. This may indicate that
WAM1 is able to limit the growth of a broader spectrum of
bacterial species, beyond those tested in this study.
Conclusions
The dwindling numbers of therapeutic options for bacterial
‘superbugs’ necessitates the development of novel antimicrobials.
The development of microbial resistance against naturally
occurring antimicrobials peptides is rare [2], and our data suggest
that the potent antimicrobial peptide gene expansions in the
platypus and tammar genomes are good candidates for discovering
natural peptides to fight multidrug resistant microbes. The strong
antimicrobial activity, salt insensitivity and low haemolytic activity
further suggest that marsupial and monotreme cathelicidin
peptides have the potential to provide novel therapeutic
antibiotics.
Materials and Methods
Identification of tammar and platypus cathelicidin genes
Genomic search. The PFAM cathelicidin HMMER [46]
profile (PF00666) was used to search a six-frame translated assem-
bly of the tammar wallaby genome (1.0). Gene predictions were
performed using FGENESH+ [47] based on HMMER results.
These were confirmed by BLAST [48] against NCBI’s protein nr
database. Platypus and tammar cathelicidin sequences can be
downloaded from http://hp580.angis.org.au/tagbase/gutentag/.
GenBank Accessions for previously published cathlicidin sequen-
ces [32,34] are MaeuCath1 EF624481.1, MaeuCath2 EF62448
2.1, MaeuCath3 EF624483.1, MaeuCath4 EF624484.1, Maeu
Cath5 EF624485, MaeuCath6 EF624486.1, MaeuCath7 EF62
4487.1, MaeuCath8 EU883635.1.
Gene expression of cathelicidin genes. All experiments
were approved by the University of Melbourne Animal
Experimentation Ethics Committee and the animal handling
and husbandry procedures were in accordance with the National
Health and Medical Research Council of Australia (2004)
guidelines. Pregnancy was initiated in females carrying an
embryo in diapause by the removal of their pouch young (RPY)
[49,50]. Adult females carrying fetuses in the final third of
gestation (day 19–26/birth) or pouch young (day 0–350) were
euthanised either by cervical dislocation or by an anaesthetic
overdose (sodium pentobarbitone, 60 mg/ml, to effect) and
portions of the suckled mammary gland and pouch skin were
collected and snap frozen in liquid nitrogen. Pouch young (PY)
skin also was collected from both male and female animals of
various ages. Tissues were homogenized and total RNA was
extracted from mammary glands using RNeasy Lipid Tissue
Table 4. WAM1 activity in the presence of high
concentrations of NaCl.
MIC (mM)
0 mM NaCl
MIC (mM)
150 mM NaCl
MIC (mM)
200 mM NaCl
P. aeruginosa
ATCC 27853
0.9 0.9 0.9
A. baumannii
ATCC 19606
1.9 1.9 3.8
K. pneumoniae
ATCC 13883
0.5 0.9 0.9
doi:10.1371/journal.pone.0024030.t004
Figure 3. Time course of K. pneumoniae killing by WAM1 in broth. Time marked in minutes. [MIC] = 0.47 mM. Antimicrobial assays were
performed as described previously [57].
doi:10.1371/journal.pone.0024030.g003
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Tri-Reagent (Ambion #AM9738) as described by the
manufacturer with a final elution of RNA in 60–80 mlo f
RNAsecure H2O (Ambion, Geneworks, # AM7005) in a
dilution of 1/24 ml. Total RNA was DNase treated (DNA-
freeTM, Ambion, # 1906) to remove contaminating genomic
DNA, quantified with a nano-spectrometer (NanaDrop ND-1000
Spectrophotometer, NanoDrop Technologies Inc, Wilmington,
DE, USA) and cDNA was synthesized with SuperScript III First
Strand Synthesis System for RT-PCR (Invitrogen, # 11904-018).
Typically 2000 ng or a maximum of 8 ml of total RNA was used in
each cDNA synthesis reaction, with 1 ml of Oligo (dT)12–18
(50 mM). cDNA integrity was immediately assessed with GAPDH
RT-PCR (Table 1). Approximately 0.5–1 ml (50–100 ng) of
template was used with 0.5 mM of each primer (table 1) with
GoTaq Green Master Mix (PROMEGA, # M7122) RT-PCR
cycles consisted of 94uC for 1 min, followed by 35 cycles of 15 sec
at 94uC, 30 sec at 60–63uC, and 40 sec at 72uC, and a final
extension at 72uC for 5 min. PCR products were resolved by gel
electrophoreses and a band of each cathelicidin was extracted
(QIAquick Gel Extraction Kit, Qiagen, # 28704) for direct
sequencing. Sequences were assessed with FinchTV (v.1.3.1) DNA
sequence chromatogram trace viewer software to confirm correct
amplification. Cathelicidin expression RT-PCRs were performed
Figure 4. Toxicity of WAM1 on human red blood cells. Haemolytic activity was determined by treating human red blood cells with different
concentrations of WAM1 and haemoglobin release measured by absorbance at 450 nm. Samples were incubated at 37uC for 1 hour. PBS and 1%
Tween-20 were used as negative and positive controls, representing 0% and 100% hemolytic activity respectively.
doi:10.1371/journal.pone.0024030.g004
Table 5. Bacteria identified by 16S rDNA sequencing from
the pouch of the tammar wallaby around the time of birth.
Time of colony
isolation 16S rDNA identification
Percentage
match
Day(-6) Bacillus licheniformis 100%
Day(-5) Bacillus licheniformis 100%
Day(-5) Devriesea agamarum
a. 94%
Day(-5) Staphylococcus equorum 99%
Day(-2) Corynebacterium tuscaniense
a. 95%
Day(-2) Bacillus cereus 99%
Day(0) Escherichia coli 100%
Day(0) Acinetobacter baumannii 100%
Day(0) Corynebacterium urealyticum 98%
Day(0) Enterobacter aerogenes 100%
Day(0) Corynebacterium coyleae
a. 95%
Day(0) Devriesea agamarum
a. 95%
Day(+1) Devriesea agamarum
a. 95%
Day(+1) Escherichia coli 100%
Day(+1) Acinetobacter baumannii 100%
a.The low sequence homology observed in these isolates suggests that they
may be a novel bacterial species and/or genus. Day (-6, 5, 2) etc indicates 6, 5
and 2 days before birth; Day(0) is day of birth; Day(+1)is the day after birth.
doi:10.1371/journal.pone.0024030.t005
Table 6. Primer sequences for cathelicidin sequence
expression analysis.
Cathelicidin Primer Primer sequence (59 to 39)
Length
(bp)
3 Fw AGTGGGTGAAAAAGTTAAGACCAG 198
Rv TATGAGAAGAAGGGTGAGGGTAAG
1,2,4,5,6,7 Fw CCATACCAGGATGTGCTGAAT
1 Rv ACAGGAGGCTACCCTGGCAGT 413
2 Rv AGTCAGAATCCCTTCCCAGCC 245
4 Rv AGTCAGACTCCCTCCCTAGTC 242
5 Fw CATGCAGGTACTCCTATTGGTGCTG 190
Rv AATGCATTGTTTCACCAGCTCCTC
7 Rv ATCATCCCCGAGTTTCGTCAC 345
8 Fw ATCTACTCTCCTTCACCCAATCAG 126
Rv GGATACTGAGCCTTGACATTCTTT
GAPDH Fw CCTACTCCCAATGTATCTGTTGTGG 351
Rv GGTGGAACTCCTTTTTTGACTGG
doi:10.1371/journal.pone.0024030.t006
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each age group were used to assess the expression patterns in the
mammary gland throughout lactation and in the skin throughout
development. All primers were designed using Primer3 (v. 0.4.0)
[51] and synthesised by Sigma-Aldrich.
Construction of phylogenetic tree shown and divergence
dating
The phylogenetic tree was constructed using the prepro region
(cathelindomain)ofthepeptidesequencesusingtheneighbor-joining
method with Jones-Taylor-Thornton amino-acid substitution as
implemented by MEGA4 [52]. Amino-acid substitution model was
identified with ProtTest [53] using Bayesian information criterion.
We used partial deletion and gamma distribution for variation
among sites (shape parameter=1.0) in MEGA4 [52]. Divergence
dating was performed using BEAST v1.5. Tree prior was defined by
Yule process. The BLOSUM 62 amino-acid substitution model was
used. We used an uncorrelated log-normal relaxed-clock model to
account for lineage-specific heterogeneity. A log-normal calibration
node defined at boreoeutheria divergence [54]. Priors for each
parameter followed a normal distribution with a standard deviation
of 0.5 million years. Monte Carlo stimulations were run for
10,000,000 steps and 10,000 trees were stored and 9,000 trees
summarized. Accessionnumbers: tammar1- ABV01938.1,tammar2
- ABV01939.1, tammar3 - ABV01940.1, tammar4 - EF624484.1,
tammar5 - ABV01941.1, tammar6 - ABV01942.1, tammar
7 - ABV01943.1, tammar8 - ACJ76797.1, human - NP_004336.2,
mouse - AAB88303.1, chicken1 - NP_001001605.1, chicken
2 -Q2IAL7.1, chicken3 - AAZ65841.1, cow1 - P22226, cow
2 - P19660, cow3 - P19661, cow4 - P33046, cow5 - P54229, cow6
- P54228, cow7 - P56425, sheep1 - P54230, sheep2 - P82018, sheep
3 - P79362, sheep4 - P50415, sheep5 - P49928, sheep6 - P49929,
sheep7 - P79361, sheep8 - O19031, sheep9 - O19040, sheep
10 - P79360, pig1 - P15175, pig2 - P51524, pig3 - P32194, pig
4 - P32195, pig5 - P32196, pig6 - P49933, pig7 - P49934, pig
8 - P49930, pig9 - P49931, pig10 - P49932, pig11 - P80054.
Prediction and screening of ancestral tammar
cathelicidin mature peptides
A mature peptide consensus sequence was generated using three
prediction methods for ancestral sequence: PAML [36], GASP [37]
and Ancescon [38]. Previously cloned and sequenced tammar
cathelicidin sequences were used as input (ABV01941.1,
ABV01938.1, ABV01939.1, ABV01940.1, ABV01942.1, AB
V01943.1).
Pouch microbe analysis
Pouch swabs were taken before birth (day 6 – 2), the day of birth
(day 0) or one day after birth (day +1) from four wallabies by gently
rubbing a sterile cotton swab over the mammary glands and around
the bottom of the pouch. Swabs were then used to inoculate Nutrient
Agar, Horse Blood Agar and MacConkey Agar. Plates were
incubated aerobically for 24–48 hours at 37uC. Selected colonies
werethenidentified by16SrDNA sequencing.Theclosestgenusand
species match for each selected colony (%) are shown in Table 5.
Antimicrobial assays
Peptides were synthesized and HPLC purified (AusPep Pty Ltd).
The two-stage radial diffusion assay used in this study has been
described elsewhere [55]. Briefly, ,4610
6 of mid-logarithmic-
phase organisms were mixed into 10 ml of warm 0.8% agarose
containing 0.03% (w/v) Trypticase soy broth (TSB) powder
buffered with 10 mM sodium phosphate, pH 7.4. The synthetic
peptides were serially diluted in 0.01% acetic acid and 5 ml peptide
samples were loaded in 2.5 mm diameter wells. The plates were
covered, and incubated at 37uC. After 3 hours, a 10 ml overlay gel
composed of 6% TSB, 0.8% agarose in 10 mM sodium phosphate
buffer (pH 7.4) was poured onto the plates. The plates were
incubated overnight to allow the surviving organisms to form
microcolonies. The clear zone was measured using a magnified
transilluminator and expressed in units (1 mm =10 U) after
subtracting the well diameter. The MIC is defined by the x
intercept of a regression line through zone diameters obtained
from a series of serially diluted peptide samples. For multidrug-
resistant bacteria, MICs were measured as described by micro-
broth dilution in Mueller-Hinton broth (Oxoid, Hampshire,
England) according to according to Clinical and Laboratory
Standards Institute (CLSI) standards [56]. The MIC measurements
were performed in duplicate and the data incorporated into a final
MIC using standard methods. All the bacterial strains were tested
on at least two different occasions. Mid-logarithmic phase cultures
of P. aeruginosa 19056 muc were diluted in Mueller–Hinton broth
to yield approximately 10
6 cfu/ml. Peptides were added at the
indicated concentrations and the suspensions were then incubated
for different times in a shaking water bath at 35uC. At the end of
each incubation time, the samples were serially diluted in buffered
saline and plated onto nutrient agar with a spiral plater (Don
Whitley Scientific, Australia). Colonies were counted after 17–
22 h incubation at 35uC using an automatic colony counter (Don
Whitley Scientific, Australia).
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